Qianglan Lu

1.1k total citations
30 papers, 975 citations indexed

About

Qianglan Lu is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Qianglan Lu has authored 30 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biomedical Engineering, 11 papers in Molecular Biology and 11 papers in Materials Chemistry. Recurrent topics in Qianglan Lu's work include Nanoplatforms for cancer theranostics (22 papers), Advanced Nanomaterials in Catalysis (11 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Qianglan Lu is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), Advanced Nanomaterials in Catalysis (11 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Qianglan Lu collaborates with scholars based in China and Thailand. Qianglan Lu's co-authors include Lifang Yang, Yilin Song, Nan Li, Siyu Wang, Fengping Tan, Peishan Li, Shan Yang, Min Xu, Yu Cheng and Yujun Song and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Qianglan Lu

29 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianglan Lu China 19 725 443 270 226 123 30 975
Na Yoon Kim United States 11 614 0.8× 382 0.9× 446 1.7× 233 1.0× 103 0.8× 13 1.1k
Qunfang Zhou China 11 537 0.7× 440 1.0× 231 0.9× 188 0.8× 55 0.4× 25 946
Xiaotong Cheng China 13 758 1.0× 551 1.2× 331 1.2× 257 1.1× 45 0.4× 25 1.1k
Mingwan Shi China 13 681 0.9× 401 0.9× 288 1.1× 161 0.7× 67 0.5× 28 902
Yinying Pu China 21 1.1k 1.6× 578 1.3× 476 1.8× 358 1.6× 190 1.5× 29 1.6k
Haoan Wu China 20 687 0.9× 411 0.9× 290 1.1× 479 2.1× 77 0.6× 41 1.1k
Lihua Kang China 12 763 1.1× 768 1.7× 424 1.6× 139 0.6× 104 0.8× 13 1.3k

Countries citing papers authored by Qianglan Lu

Since Specialization
Citations

This map shows the geographic impact of Qianglan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianglan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianglan Lu more than expected).

Fields of papers citing papers by Qianglan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianglan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianglan Lu. The network helps show where Qianglan Lu may publish in the future.

Co-authorship network of co-authors of Qianglan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qianglan Lu. A scholar is included among the top collaborators of Qianglan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianglan Lu. Qianglan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Yongchun, Fei Zeng, Xiaowei Luan, et al.. (2025). Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy. Advanced Materials. 37(13). e2411886–e2411886. 5 indexed citations
2.
Lu, Qianglan, Fei Zeng, Zhiyong Liu, et al.. (2025). Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis. ACS Nano. 19(25). 23162–23176.
3.
Lu, Qianglan, Shuai Ding, Yamei Gao, et al.. (2025). Spatiotemporally delivery of Cas9 ribonucleoprotein/DNAzyme logic systems using near-infrared upconversion nanomachine for precise immunotherapy. Acta Pharmaceutica Sinica B. 15(10). 5431–5443. 2 indexed citations
4.
Liu, Zhiyong, Xiaowei Luan, Qianglan Lu, et al.. (2025). Reactive oxygen species responsive nanomotors for gene edited metabolic disruption and immunotherapy. Nature Communications. 16(1). 4708–4708. 6 indexed citations
5.
Chen, Ruiyue, Qianglan Lu, Fei Zeng, et al.. (2024). A bioorthogonal probiotic platform spatiotemporally releases nanobodies in deep tumor for cancer chemoimmunotherapy. Materials Today. 80. 262–275. 3 indexed citations
6.
Lu, Qianglan, Ruiyue Chen, Fei Zeng, et al.. (2024). Inhalation of Bioorthogonal Gene‐Editable Spiky‐Pollen Reprograms Tumor‐Associated Macrophages for Lung Cancer Immunotherapy. Advanced Functional Materials. 34(48). 2 indexed citations
7.
Qin, Shurong, H. J. Yang, Fei Zeng, et al.. (2024). Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes. ACS Nano. 18(39). 26858–26871. 20 indexed citations
8.
Pan, Yongchun, Fei Zeng, Shurong Qin, et al.. (2024). Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis. ACS Nano. 18(12). 9031–9042. 45 indexed citations
9.
Zeng, Fei, Yongchun Pan, Qianglan Lu, et al.. (2024). Self‐Generating Gold Nanocatalysts in Autologous Tumor Cells for Targeted Catalytic Immunotherapy. Advanced Healthcare Materials. 13(14). e2303683–e2303683. 3 indexed citations
10.
Lu, Qianglan, Yongchun Pan, Yiqun Jiang, et al.. (2023). Tumor-associated miRNAs activated HCR-DNAzyme theranostic nanosystem to trigger innate- and adaptive-immune responses for long-term immunotherapy. Chemical Engineering Journal. 473. 145192–145192. 9 indexed citations
11.
Pan, Yongchun, Xiaowei Luan, Fei Zeng, et al.. (2023). Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy. Acta Pharmaceutica Sinica B. 14(2). 795–807. 12 indexed citations
12.
Lu, Qianglan, Ruiyue Chen, Chao Chen, et al.. (2022). Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy. Biomaterials. 291. 121871–121871. 56 indexed citations
13.
Wang, Tingting, Guangxu Xiao, Qianglan Lu, et al.. (2022). Synergistic Lysosomal Impairment and ER Stress Activation for Boosted Autophagy Dysfunction Based on Te Double‐Headed Nano‐Bullets. Small. 18(27). e2201585–e2201585. 11 indexed citations
14.
Luan, Xiaowei, Yongchun Pan, Yuyu Zhou, et al.. (2022). Targeted Self‐assembly of Renal Clearable Cu2‐xSe to Induce Lysosome Swelling for Multimodal Imaging Guided Photothermal/Chemodynamic Synergistic Therapy. Advanced Functional Materials. 32(51). 21 indexed citations
15.
Lu, Qianglan, Tong Lu, Min Xu, et al.. (2020). SO2 prodrug doped nanorattles with extra-high drug payload for “collusion inside and outside” photothermal/pH triggered - gas therapy. Biomaterials. 257. 120236–120236. 74 indexed citations
16.
Xu, Min, Qianglan Lu, Yilin Song, et al.. (2020). Enhanced Bax upregulating in mitochondria for deep tumor therapy based on SO2 prodrug loaded Au–Ag hollow nanotriangles. Biomaterials. 250. 120076–120076. 42 indexed citations
17.
18.
Wang, Siyu, Qing You, Jinping Wang, et al.. (2019). MSOT/CT/MR imaging-guided and hypoxia-maneuvered oxygen self-supply radiotherapy based on one-pot MnO2-mSiO2@Au nanoparticles. Nanoscale. 11(13). 6270–6284. 62 indexed citations
19.
Yang, Lifang, et al.. (2019). Rod-shape MSN@MoS2 Nanoplatform for FL/MSOT/CT Imaging-Guided Photothermal and Photodynamic Therapy. Theranostics. 9(14). 3992–4005. 65 indexed citations
20.
Yang, Shan, Qing You, Lifang Yang, et al.. (2019). Rodlike MSN@Au Nanohybrid-Modified Supermolecular Photosensitizer for NIRF/MSOT/CT/MR Quadmodal Imaging-Guided Photothermal/Photodynamic Cancer Therapy. ACS Applied Materials & Interfaces. 11(7). 6777–6788. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Yoon Kim Breakdown of academic impact, for papers by Qunfang Zhou Breakdown of academic impact, for papers by Xiaotong Cheng Breakdown of academic impact, for papers by Mingwan Shi Breakdown of academic impact, for papers by Yinying Pu Breakdown of academic impact, for papers by Haoan Wu Breakdown of academic impact, for papers by Lihua Kang
Rankless by CCL
2026